Company updateMoneycontrol
Anand Rathi raises Global Health target to Rs 1710
Positive+31
GreyOak summary
Anand Rathi reported Global Health's strong Q2FY27 results, with revenue and EBITDA rising 34% and 60% year-on-year. The Noida unit turned profitable, driving overall growth. The broker maintains a BUY rating with a revised target price of Rs 1,710.
What it affects
- Global HealthMEDANTAPositive +31
Revenue and EBITDA rose 34% and 60% respectively.Rolling sentiment Positive +35
Source
Read the original at MoneycontrolMore Global Health news
No other recent stories about Global Health.
All Global Health news →